Abstract The gut microbiome may modulate intestinal immunity by luminal conversion of dietary amino acids to biologically active signals. The model probiotic organism Lactobacillus reuteri ATCC PTA 6475 is indigenous to the human microbiome, and converts the amino acid L-histidine to the biogenic amine, histamine. Histamine suppresses tumor necrosis factor (TNF) production by human myeloid cells and is a product of L-histidine decarboxylation, which is a proton-facilitated reaction. A transposon mutagenesis strategy was developed based on a single-plasmid nisin-inducible Himar1 transposase/transposon delivery system for L. reuteri. A highly conserved proton-chloride antiporter gene (eriC), a gene widely present in the gut microbiome was discovered by Himar1 transposon (Tn)-mutagenesis presented in this study. Genetic inactivation of eriC by transposon insertion and genetic recombineering resulted in reduced ability of L. reuteri to inhibit TNF production by activated human myeloid cells, diminished histamine production by the bacteria and downregulated expression of histidine decarboxylase cluster genes compared to those of WT 6475. EriC belongs to a large family of ion transporters that includes chloride channels and proton-chloride antiporters and may facilitate the availability of protons for the decarboxylation reaction, resulting in histamine production by L. reuteri. This report leverages the tools of bacterial genetics for probiotic gene discovery. The findings highlight the widely conserved nature of ion transporters in bacteria and how ion transporters are coupled with amino acid decarboxylation and contribute to microbiome-mediated immunomodulation.
Introduction
Probiotic Lactobacillus reuteri is indigenous to the gastrointestinal tract of humans, pigs, mice, rats, and birds . Previous studies demonstrated host-specificity within this species, suggesting that physiological and immunological differences between different vertebrates contributed to host-driven evolution of L. reuteri (Frese et al. 2011) . L. reuteri is generally regarded as safe and has never been shown to cause diseases in humans (Britton and Versalovic 2008) . Human-derived L. reuteri strains hold the potential to be both preventive and therapeutic probiotic treatments of inflammatory diseases. Specifically, L. reuteri ATCC PTA 6475 houses a histidine decarboxylase (hdc) gene cluster important for histamine production, which is characteristic of human-derived L. reuteri strains (Frese et al. 2011) .
Results from comparative genomics analysis of human-derived L. reuteri strains also demonstrated the presence of hdc gene cluster almost exclusively in strains that are members of multi-locus sequence analysis (MLSA) clade II (Oh et al. 2010, JK Spinler, unpublished data) . L.reuteri 6475-derived histamine activates histamine receptor type 2 (H 2 ) on toll-like receptor 2 (TLR2)-activated human myeloid cells resulting in decreased tumor necrosis factor (TNF) production and inhibition of MEK/ERK MAPK signalling. (Thomas et al. 2012 ). Supplementation of Lhistidine in L. reuteri 6475 growth medium increases the expression of the hdc gene cluster and production of TNF-inhibitory histamine (Thomas et al. 2012) . A mutant strain deficient in Lactobacillus reuteri-Specific Immunoregulatory (RsiR) gene did not produce histamine and did not protect mice in a trinitrobenzene sulfonic acid (TNBS)-induced mouse model of acute colitis (Hemarajata et al. 2013 ). However, little is known about the regulatory mechanism of histidine decarboxylation by L. reuteri and the physiological changes that occur in the bacterial cell during histamine production.
Genetic manipulation of L. reuteri is a challenge and had been limited to a few targeted mutagenesis techniques until now (Walter et al. 2005; Su et al. 2011) . Transposon-based mutagenesis strategies can be robust techniques for identifying unknown genes involved in functional areas (Picardeau 2009 ). The eukaryotic transposable Mariner element, Himar1, from the hornfly Haematobia irritans, has been used successfully in generating mutations in many prokaryotic organisms, such as Enterococcus faecalis (Kristich et al. 2008) , Bacillus anthracis (Tam et al. 2006) , Bacillus subtilis (Le Breton et al. 2006; Pozsgai et al. 2011) and Clostridium perfringens (Liu et al. 2013) . Himar1 transposable elements have also been employed in genetically intractable organisms such as Leptospira interrogans (Bourhy et al. 2005) , Francisella tularensis (Maier et al. 2006) and Coxiella burnetii (Beare 2012). Himar1 transposase activity is independent of eukaryotic host cofactors (Lampe et al. 1998) , and has little insertion site specificity, requiring only the dinucleotide TA in the target sequence (Akerley et al. 1998) , which makes it an attractive candidate for transposonbased mutagenesis in prokaryotic organisms.
There are various approaches for delivering and expressing the Himar1 transposase gene and its transposable elements in prokaryotes. Previous studies have utilized conditionally replicative plasmids as delivery vectors, that can be eliminated after successful transposition (Picardeau 2009 ). Others have employed Lactococcus lactis-derived nisin-inducible expression systems to control transposase production (Kristich et al. 2008) . Most studies approach the Himar1 transposon mutagenesis strategy in dualplasmid systems (Kristich et al. 2008; Tam et al. 2006; Beare et al. 2009) . In this study, we developed a transposon mutagenesis system for L. reuteri with the intent to identify unknown genes important for the anti-inflammatory phenotype of L. reuteri 6475. We constructed a conditionally replicative plasmid to contain both a nisin-inducible Himar1 transposase and transposon and introduced it into L. reuteri. Libraries of transposed mutants were selectively screened for their loss of the ability to inhibit TNF production from human myeloid cells. An insertion in a gene encoding a proton-chloride antiporter (EriC) was identified by whole genome sequencing, and is an important member of the immunomodulatory gene network of L. reuteri.
Materials and methods

Bacterial strains and culture conditions
All bacterial strains used in this study are described in Supplemental Table S1 . L. reuteri strains were routinely cultured in deMan, Rogosa, Sharpe media (MRS; Difco, Franklin Lakes, NJ) at 37°C in an anaerobic workstation (MACS MG-500, Microbiology International, Frederick, MD) supplied with a mixture of 10 % CO 2 , 10 % H 2 , and 80 % N 2 (Airgas, the Woodlands, TX). Escherichia coli strains were routinely cultured in Luria-Bertani broth (LB; Invitrogen, Carlsbad, CA) at 37°C and 220 rpm shaking for 16-18 h. Specific culture conditions for individual experiments are detailed throughout. When appropriate, antibiotics were added in the following concentrations: chloramphenicol (Cm, 10 lg/mL), erythromycin (Erm, 10 lg/mL) for L. reuteri; carbenicillin (Cb, 50 lg/mL), chloramphenicol (30 lg/mL,) erythromycin (400 lg/mL) and kanamycin (Kn, 40 lg/mL) for E. coli.
Construction of a single-plasmid, nisin-inducible Himar1 expression system (pPH-M1)
All plasmids and primers used in this study are detailed in Table S1 . A temperature-sensitive, E. coli-L. reuteri shuttle vector containing a nisin-inducible Himar1 transposase and Himar1 transposon (Tn) was constructed in several steps. The nisin-inducible Himar1 expression cassette (NICEHim1) was assembled using the In-Fusion Ò HD Cloning System (Clontech, Mountain View, CA) in two multi-fragment cloning steps. In the first multi-fragment cloning step, the P nisA promoter and nisRK element were amplified from the chromosome of L. lactis subsp. lactis ATCC 11454 with primers containing an AatII site strategically engineered downstream from the P nisA promoter. Amplicons were cloned into an EcoRI restriction site in pCR Ò 2.1 (Invitrogen, Carlsbad, CA) by standard cloning methods. Next, translational terminator T667 and the Himar1 transposase gene (him1C9) were cloned into this AatII site as follows: T667 was amplified from pTRK847 (a gift from Dr. T. R. Klaenhammer, North Carolina State University, Raleigh, NC), and him1C9 was amplified from pMALC9 (Akerley and Lampe 2002) . AatII sites introduced by the primer sets of both T667 and him1C9 enabled the amplicons to be cloned into the AatII site downstream of the P nisA promoter now in pCR The second multi-fragment cloning step involved the assembly of a Himar1 transposon (HimTn) to contain in order: translational stops, a constitutive P 23 promoter (Que et al. 2000) , and an Erm resistance gene (ermR) from pORI28 (Leenhouts et al. 1996) into a BglII site between the 5 0 and 3 0 inverted terminal repeats (ITRs) recognized by the Himar1 transposase in pMMOrf (Lampe et al. 1999) .
Lastly, elements generated in the above steps along with a pUC origin of replication (ori) were combined into pVE6007 (Law et al. 1995) to create the NICEHim1 system for use in L. reuteri. Plasmid pVE6007 is temperature sensitive and replicates in L. reuteri. The In-Fusion Ò HD Cloning System was used to transfer the pUC ori from pUC19 into the SacI restriction site in pVE6007 to create a single vector capable of replicating in both L. reuteri and E. coli. Subsequently, the NICEHim1 cassette (from pCR Ò 2.1-NICEHim1) was sub-cloned into the pVE6007 EagI site, followed by HimTn into a BamHI site, resulting in pPH-M1 (Fig. 1) . Fig. 1 The Himar 1 transposase/transposon delivery vector, pPH-M1, generated for Himar1 transposon (Tn) mutagenesis in L. reuteri. Genes for the Himar1 transposase, selective antibiotic resistance cassettes, nisin-inducible expression system and elements important for transposition were all combined into a single, conditionally replicative vector for use in L. reuteri. Conditional replication is temperature-dependent, and an increase in temperature to 45°C results in plasmid elimination. cat chloramphenicol resistance gene, ermR erythromycin resistance gene, ITR inverted terminal repeats (ITRs) recognized by the Himar1 transposase, STOP CODONS translational stop codons, P 23 constitutive P 23 promoter, nisR and nisK two-component regulatory elements required for nisin-induced expression system, Term 667 translational stop codons, himar1C9 hyperactive mutant of Himar1 transposase, P nisA promoter for nisin-induced expression system, pUC Ori origin of replication for E. coli, repA(Ts) gene encoding temperature sensitive mutant of replication factor RepA, required for replication in L. reuteri
Induction of Himar1 expression and transposition
Lactobacillus reuteri 6475 pPH-M1 was used to generate a library of Himar1 Tn-mutant clones. L. reuteri 6475 pPH-M1 was generated by electroporation (2 mm cuvettes, 2,500 V, 25 lF and 400 X) and cultured overnight in MRS with 10 lg/mL Cm (Cm 10) and 10 lg/mL Erm (Erm 10) at 30°C anaerobically. The overnight culture was subcultured into fresh MRS Cm 10 Erm 10 at an OD 600 = 0.05 and incubated at 30°C anaerobically for 4 h. Expression of Himar1 transposase was induced by the addition of purified nisin (Sigma-Aldrich, St. Louis, MO) at a final concentration of 50 ng/mL (Wu et al. 2006) , followed by anaerobic incubation at 30°C for 16 h. Elimination of the thermosensitive pPH-M1 was subsequently performed as previously described with some modifications (Walter et al. 2005) . Briefly, consecutive subculturing at 45°C (first for 8 h, then overnight) was carried out in MRS Erm10 using the nisin-induced culture as the initial inoculum. Dilutions of the final subculture were plated on MRS Erm10 agar and incubated anaerobically at 45°C overnight. Isolated colonies were replica-plated onto MRS Erm10 and MRS Cm10 agar, and incubated at 37°C overnight. A diagram of the mutagenesis process is depicted in Supplemental Fig. 1 . Erm-resistant, Cm-sensitive isolates were cultured in 200 lL MRS Erm 10 in 96-well plates overnight, mixed with 20 % glycerol and stored at -80°C as our Himar1 transposon (Tn)-mutant library.
Southern hybridization
Southern hybridization of digested genomic DNA (gDNA) was performed using DIG-High Prime DNA Labeling and Detection Starter Kit I (Roche, Indianapolis, IN). Briefly, digoxigenin (DIG)-labeled probe was prepared by amplifying ermR from pPH-M1 with primers ErmR-F and ErmR-R according to manufacturer's instructions. Five micrograms of concentrated gDNA from each mutant and control isolate were digested by HindIII. Digested DNA fragments were separated by 1 % agarose gel electrophoresis, transferred to a nylon membrane by capillary transfer, and hybridized to the DIG-labeled probe as per manufacturer's instructions. The presence of ermR was detected colorimetrically using the anti-digoxigenin-AP conjugate and nitro blue tetrazolium substrate.
High-throughput screening of mutant libraries for reduction in TNF inhibitory activity High-throughput preliminary screening of Tn-mutants for loss of TNF inhibition was carried out as follows. Using a plate replicator, 96-well plates (200 lL MRS Erm10/well) were inoculated with Tn-mutants from our frozen library and incubated anaerobically for 24 h at 37°C. Overnight cultures (40 lL) were subcultured in 96-well plates of LDMIII (Erm 10, 200 lL/well) and incubated as described. Culture supernatants were filter-sterilized and collected using 0.22 lM PVDF 96-well filter plates (Millipore, Billerica, MA), followed by subsequent size-exclusion using 10 kDa 96-well filter plates (Millipore, Billerica, MA). Supernatants were vacuum dried (Eppendorf, Hamburg, Germany) and resuspended with an equal volume of RPMI prior to use in TNF inhibitory bioassays.
Detection of chromosomal insertion sites using whole genome shotgun (WGS) sequencing Genomic DNA was isolated from Tn-mutants showing loss of TNF inhibition using the QIAamp DNA Mini Kit with the QIAcube automation system (QIAGEN, Valencia, CA), and was processed and bar-coded using the Illumina TruSeq DNA sample preparation workflow (Illumina Inc, San Diego, CA). Bar-coded samples from all mutants were analyzed in a multiplexed single flow cell on the Illumina MiSeq Ò platform (Illumina Inc, San Diego, CA) with pairedend 150-bp read lengths. To enhance the efficiency identification of transposon insertion sites and maximize the length of contigs, sequences were assembled de novo using Velvet Assembler (Zerbino and Birney 2008) . Assembled genome contigs were aligned to the L. reuteri 6475 draft genome (GenBank accession numbers NZ_ACGX02000001 through NZ_ACGX02000007) and transposon insertion sites were identified by searching for known Himar1 transposon complete sequence (1,365 bp) in genome contigs followed by analysis of the DNA sequences surrounding each insertion.
Construction of L. reuteri eriC recombineered mutant (6475eriC-Stop)
The target gene, eriC, was mutated by recombineering techniques in L. reuteri 6475 as previously described with modifications Hemarajata et al. 2013) . Both the control plasmid (pJP577) carrying a chloramphenicol resistance (cat) gene and the eriC mutagenesis recombineering oligo (o384stop) were simultaneously electroporated into L. reuteri 6475 pJP042 (ermR). Plasmid pJP577 was used as a measure of transformation efficiency, and o384stop was designed to introduce translational stops at amino acids 2, 4 and 5 of eriC. Candidate recombineered mutant colonies of L. reuteri 6475 were selected for growth on MRS Cm 10 and successively screened by mismatch amplification mutation assay (MAMA)-PCR using primers homologous to the desired mutation and sequences flanking the mutation site (KJP73, KJP74 and KJP75, respectively). PCR-positive colonies were verified by sequencing. The two recombineering plasmids (pJP042 and pJP577) were cured by successive passaging of overnight cultures in MRS until susceptibility to Cm 10 and Erm 10 was achieved.
Tumor necrosis factor inhibition bioassay
Tumor necrosis factor inhibition bioassay and TNF ELISA were performed as previously described (Thomas et al. 2012) . Briefly, overnight MRS cultures (described above in bacterial strains and culture conditions) were inoculated into 10 mL semi-defined media, LDMIII (OD 600 adjusted to 0.1) and grown for 24 h at 37°C. After centrifugation at 4,0009 g for 10 min, bacteria cell-free supernatants were filtersterilized and size-fractionated to select for factors smaller than 3 kDa in size. Supernatants underwent vacuum drying and normalization by resuspension in RPMI medium to OD 600 = 1.5. Normalized supernatants were tested for their ability to modulate TNF production in myeloid cells THP-1 cells. Cells (5 9 10 4 cells) were treated with L. reuteri supernatant (5 % v/v) and activated by 100 ng/mL Pam 3 Cys-SKKKK 9 3 HCl, a TLR-2 agonist (EMC Microcollections, Tüebingen, Germany) as previously described (Lin et al. 2008) . After incubation at 37°C and 5 % CO 2 for 3.5 h, quantitative ELISAs were used to determine the concentration of TNF in THP-1 culture supernatants according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). Data were analyzed using unpaired t test on GraphPad Prism 5 software (GraphPad Inc, La Jolla, CA).
Histamine ELISA Quantitative histamine ELISA was performed as previously described (Thomas et al. 2012) . Briefly, wild-type (WT) L. reuteri 6475 and 6475eriC-Stop mutant strains were cultured in LDMIII, in the presence or absence of supplemental 4 mg/mL Lhistidine. (The addition of 4 mg/mL L-histidine was determined by titration (0.2-4 mg/mL). A plateau in histamine production from WT 6475 was observed when the concentrations of supplemental L-histidine approached 4 mg/mL (data not shown). Culture supernatants were harvested at 24 h, filter-sterilized and histamine concentrations were determined using the Histamine ELISA kit (Neogen, Lexington, KY) according to the manufacturer's instructions. Absorbance was measured with a Bio-Rad Spectramax 340PC Spectrophotometer (Bio-Rad, Hercules, CA). Data were normalized to a culture OD of 1.0, background corrected, and analyzed using unpaired t test and two-way ANOVA on GraphPad Prism 5 software.
Reverse transcription quantitative PCR
Wild-type L. reuteri 6475 and the 6475eriC-Stop mutant strain were grown in LDMIII as described above in the presence or absence of 4 mg/mL supplemental L-histidine. At 16 h post-inoculation, transcription was stopped using ice-cold methanol and cell pellets were harvested. RNA isolation from collected cell pellets and cDNA synthesis from total RNA were performed as previously described (Thomas et al. 2012) . Expression of the hdc cluster genes (hdcA, hdcB, hdcP) and the RNA polymerase b-subunit (rpoB) reference gene was analyzed using reverse transcription quantitative PCR (RT-qPCR) with previously published primers (Table S1 ). RT-qPCR reactions included 2X FastStart Universal Probe Master (Rox) (Roche Applied Science) and cDNA as template along with corresponding probes and primers at final concentrations of 100 and 200 nM, respectively. A standard curve was generated using seriallydiluted gDNA from WT L. reuteri 6475. PCR reactions were performed on the ViiA 7 Real-Time PCR System (Life Technologies, Grand Island, NY) with cycling parameters as previously described (Thomas et al. 2012) . The relative standard curve method (Larionov et al. 2005 ) was used to calculate relative changes in gene expression.
Results
Creating a system for probiotic gene discovery by Himar1 transposon mutagenesis
In transposon-mediated mutagenesis, it is essential that the transposing events occur under strict regulation to ensure stability of mutants and prevent multiple insertions. We used a nisin-inducible protein expression system to create such a system for L. reuteri. Nisin is a post-translationally modified antimicrobial peptide produced by some strains of L. lactis . Gene expression involved in nisin production by L. lactis is autoregulated by a histidine kinase two-component regulatory system, nisRK (Engelke et al. 1994) . Promoter P nisA controls gene expression of the nisin biosynthetic gene cluster by nisin-mediated autoregulation . Nisin-inducible expression systems have been widely used to regulate protein expression in other prokaryotic organisms besides L. lactis (Kleerebezem et al. 1997; Pavan et al. 2000; Wells et al. 2000) including L. reuteri (Wu et al. 2006) . For this study, we constructed pPH-M1 (Fig. 1) , which is a temperature sensitive, RepA-dependent derivative of pVE6007 (Law et al. 1995) . Plasmid pPH-M1 contains a P nisA -directed hyperactive variant of Himar1 transposase, him1C9 (Lampe et al. 1999) , along with the nisRK elements required for nisin-inducible gene expression. The pPH-M1 construct also contains an ErmR Himar1 transposon flanked by the Himar1 cognate inverted terminal repeats (ITRs).
Himar1 transposase expression from pPH-M1 was induced during exponential growth phase of L. reuteri 6475 using purified nisin at a final concentration of 50 ng/mL. After a 16-hour induction, elimination of pPH-M1 from L. reuteri Tn-mutants was carried out by successive overnight culturing at 45°C. L. reuteri::Himar1 Tn-insertion mutants were selected for growth on MRS Erm 10 and a library of 432 Cmsensitive/Erm-resistant mutants were stored at -80°C. Several L. reuteri::Himar1 mutants were randomly chosen from the library and analyzed for single insertions in different loci per Tn-mutant. PCR on gDNA isolated from these ten L. reuteri::Himar1 mutants using primers specific to the pPH-M1 cat and Himar1 Tn ermR genes confirmed that both pH-M1 elimination and Himar1 Tn-insertion were successful (data not shown). Southern hybridization on restriction enzyme-digested gDNA from a total of 16 L.reuteri::Himar1 Tn-mutants demonstrated single insertions of the Himar1 transposon in different sized DNA fragments between all but one isolate (lane 16, Supplemental Fig. S2 ). The L. reuteri::Himar1 Tnmutant represented in lane 16 (Supplemental Fig. S2 ) clearly demonstrated the presence of the Himar1 transposon in two individual chromosomal DNA fragments from the same isolate. This highlights the ability of our Himar1 Tn insert in multiple loci within the L. reuteri 6475 genome and that Himar1 transposase production was reasonably well controlled by our nisin-inducible system.
L. reuteri::Himar1
Tn mutants unable to suppress TNF contained a Himar1 Tn insertion near the promoter region of a proton-chloride antiporter (eriC) gene Preliminary high-throughput screening of 216 L. reuteri::Himar1 Tn-mutants for a loss in TNF inhibitory activity revealed nine isolates that exhibited less than 50 % TNF suppression of WT 6475 (see example screening data in Supplemental Fig. S3 ). These mutants were selected for full-scale preparation of LDMIII culture supernatants and confirmatory testing in a TNF inhibition bioassay (Fig. 2) . Six mutants demonstrating complete loss of TNF inhibition (A8, C2, C3, E8, F6 and F12) were selected for whole genome shotgun sequencing to determine transposon insertion sites.
A total of 14,933,818 150-bp reads from six genomes were analyzed, and the primary sequencing data generated 166-fold coverage per genome. This relatively low coverage approach yielded positive results. Analysis of genome contigs from the six mutants submitted for WGS sequencing identified transposon insertion sites in mutants A8, C2 and F6. Analysis of sequences from mutants C3, E8 and F12 did not result in significant matches with the reference genome, likely due to gaps in the draft assembly. Transposon insertions in mutants A8, C2 and F6 all occurred in the same position between nucleotides T and A (position 136149 and 136150 in WGS sequence contig 21725, respectively). This insertion is positioned within the intergenic region downstream from the APC family D-serine/D-alanine/glycine transporter gene proY (HMPREF0536_10427) and upstream from the proton-chloride antiporter gene eriC (HMPREF0536_10428) (Fig. 3) . The insertion is 7 bp downstream from the stop codon of proY, suggesting that the insertion was unlikely to affect the transcription and function of proY and its gene product. However, this insertion site was located directly upstream from the eriC predicted promoter region (P eriC , 28 bp) (Reese 2001) , transcriptional start site (68 bp), and translational start codon (74 bp). The close proximity of the insertion site to P eriC may have disrupted eriC expression and possibly contributed to a diminished effect on TNF suppression by L. reuteri 6475.
Targeted inactivation of EriC confirmed a role in TNF inhibition and histamine production by L. reuteri
To independently determine whether inactivation of eriC would result in loss of TNF inhibition, we generated stop codons to replace amino acids 2 (Alanine), 4 (Arginine), and 5 (Leucine) in the eriC gene of L. reuteri 6475 by recombineering and tested culture supernatants from the mutant strain (6475eriC-Stop) for its ability to suppress human TNF production by activated human myeloid cells. Culture supernatants from 6475eriC-Stop failed to suppress TNF production from THP-1 cells when compared to WT 6475 (Fig. 4a) . This observation confirmed that eriC is important for L. reuteri-mediated immunomodulation, and that the Himar1 Tn-insertion just upstream of eriC resulted in the discovery of a gene important for this probiotic function.
A recent study from our laboratory reported that histamine is an immunomodulatory factor produced by L. reuteri 6475 (Thomas et al. 2012) . Because inactivation of eriC resulted in the loss of TNF suppression, we wanted to determine whether histamine production by L. reuteri was affected in the 6475eriC-Stop mutant. Defined media (LDMIII) alone contained approximately 1.5 lg/mL of L-histidine (Nolan 1971) and less than 0.1 lg/mL of histamine, Fig. 2 Himar1 Tn-mutants lacked the ability to suppress TNF production by activated THP-1 cells. L. reuteri 6475 Tn-mutants that demonstrated loss of TNF inhibition in preliminary highthroughput screening were confirmed for loss of phenotype in a full-scale TNF inhibition assay. Mutants A8, C2, C3, E8, F6 and F12 consistently demonstrated loss of TNF inhibition. Data were analyzed using one-way ANOVA (p \ 0.0001) followed by Bonferroni's multiple comparison test against WT 6475 (n = 3). LDM media control, WT 6475 positive control for TNF suppression, NCS Non-TNF-suppressive L. reuteri strain (6475::rsiR) used as negative control for TNF inhibition, *p \ 0.01, **p \ 0.001, ***p \ 0.0001 Fig. 3 Location of the Himar1 insertion in L. reuteri 6475 chromosome relative to eriC. WGS sequencing data of L. reuteri::Himar1 Tn-mutants was analyzed for the presence and location of Himar1 Tn DNA. Himar1 insertion sequence was identified upstream of the eriC predicted promoter region in the L. reuteri 6475 chromosome. proY APC family D-serine/Dalanine/glycine transporter gene, bp base pairs, P eriC predicted eriC promoter, eriC proton-chloride antiporter gene as measured by ELISA (data not shown). Histamine concentrations in culture supernatants from WT 6475 (with an intact hdc gene cluster) were approximately 40 lg/mL, and increased more than 2.5-fold ([100 lg/mL) when growth media was supplemented with 4 mg/mL L-histidine. Histamine production from the 6475eriC-Stop mutant was significantly diminished compared to WT 6475 when grown in the same conditions (62 % reduction in unsupplemented media; 67 % reduction in L-histidine-supplemented media) (Fig. 4b) . These results support a role for eriC in the production of L. reuteri-derived immunomodulatory histamine, and that additional L-histidine was not converted to histamine at the same capacity as wildtype without a functional eriC gene.
Targeted interference with a functional EriC affected histidine decarboxylase (hdc) gene cluster expression
Histamine production by the 6475eriC-Stop mutant was significantly decreased compared to WT 6475. Therefore, we wanted to determine whether preventing EriC translation in 6475eriC-Stop had downstream effects on gene expression within the hdc cluster (hdcA, hdcB and hdcC). Reverse transcription quantitative PCR showed that expression of hdcA and hdcB genes in the 6475eriC-Stop mutant was significantly downregulated (3.14-and 1.52-fold downregulation, respectively) compared to that of WT 6475, while the expression of hdcP was not affected (Fig. 5a ). L-histidine supplementation elicited significant upregulation of all three hdc cluster genes in wild type L. reuteri when compared to no L-histidine supplementation (2.45-fold for hdcA, 3.20-fold for hdcB, and 2.02-fold for hdcP). Nevertheless, changes in the expression of hdcA, hdcB, and hdcP in 6475eriC-Stop were insignificant in the presence of supplemented L-histidine (Fig. 5b) . The changes in gene expression of the hdc cluster in either WT 6475 or 6475eriC-Stop was concordant with the measurements of histamine production by ELISA for each strain under the same conditions. These observations showed that inactivation of EriC resulted in the diminished ability of L-histidine to induce hdc genes involved in histamine biosynthesis.
Discussion
We identified the proton-chloride antiporter gene (eriC) as a genetic element necessary for L. reuteri-mediated immunomodulation and histamine production. We developed a single-plasmid Tn-mutagenesis system for L. reuteri 6475 using the Himar1 transposon in conjunction with a nisin-inducible Himar1 transposase. The eriC gene was identified through a combination of high-throughput selective screening of randomly selected Himar1 Tn-mutants for a loss of TNF inhibition and WGS sequencing of candidate Tn-mutants. Genetic inactivation of eriC resulted in the loss of the L. reuteri 6475's ability to suppress TNF production by activated reuteri supernatants were tested for the ability to inhibit TNF by TLR2-activated THP-1 cells. Inhibition of TNF production by recombineered 6475eriC-Stop mutant was significantly reduced when compared to WT 6475. The results are expressed as the mean ± SD, n = 3, *p value \ 0.05 compared to WT 6475 using unpaired t test (b) L. reuteri-derived histamine was quantitated by a histamine-specific ELISA and demonstrated decreased histamine production in 6475eriC-Stop compared to WT 6475 even when grown in histidine-supplemented medium. Data were normalized to final culture OD 600 = 1.0 and analyzed by two-way ANOVA. Results represent the mean ± SD (n = 3), p value \ 0.0001 compared to wild-type 6475 human myeloid cells, a diminished production of histamine, and downregulation of histamine biosynthesis genes as compared to WT 6475.
Transposon mutagenesis systems are powerful genetic tools for gene discovery ranging from those focusing on single organisms to large-scale microbiome studies. Transposon mutagenesis using Himar1 has been used to identify genetic elements in Bacteroides thetaiotaomicron required for stable colonization in mice, in the presence or absence of other members of the intestinal microbiota (Goodman et al. 2009 ). Few transposon mutagenesis systems have been described for Lactobacillus species, such as the P junc -TpaseIS 1223 system and the Tn5-based transposon system in L. casei (Ito et al. 2010; Licandro-Seraut et al. 2012) . A successful use of a transposon-based mutagenesis for gene discovery in lactobacilli was described in L. plantarum, where the pGh9:IS S1 plasmid system was used to identify genes involved in the regulation of phenolic acid metabolism (Gury et al. 2004 ). To our knowledge, our single-plasmid Himar1 transposon mutagenesis system was the first successful use of Himar1 in L. reuteri. We have only tested our Himar1 system in the plasmid-free strain, L. reuteri 6475. Other L. reuteri strains containing multiple native plasmids such as L. reuteri ATCC 55730 or DSM 17938 (Rosander et al. 2008 ) are less amenable to genetic manipulation. However, this Himar1 system was built into a plasmid (pVE6007) known to replicate in multiple L. reuteri strains, and we postulate that it could be used as a gene discovery tool for them as well.
We screened Himar1 Tn-mutants and observed a phenotypic alteration in the loss of TNF suppression. Identification of transposon insertion sites in mutants that failed to inhibit TNF production by THP-1 cells in our preliminary screenings revealed disruptions of the intergenic region near the predicted promoter for proton-chloride antiporter gene (eriC). EriC (also called CIC-ec1) is part of the biologically-ubiquitous chloride ion channel (CIC) superfamily of proteins, which includes chloride channels and proton-chloride antiporters (Chen 2005) . Proteins in the CIC superfamily are expressed in species ranging from bacteria to human. However, EriC possesses a unique protonchloride antiporter activity extensively characterized in E. coli. Despite the differences in the functions between the two types of CIC proteins, all members of this superfamily contain double-barreled architecture and possess voltage-dependent gating mechanism (Maduke et al. 2000) . EriC is a homodimeric transmembrane protein and exchanges protons with chlorides in a fixed 2:1 stoichiometry (Kieseritzky and Knapp 2010) . Results from protein BLAST with L. Fig. 5 Expression of the hdc gene cluster was affected by a mutation in eriC. a Gene expression of the hdc cluster in 6475eriC-Stop was compared to that of WT 6475. RT-qPCR demonstrated decreased expression of hdcA and hdcB genes in the EriC-deficient mutant compared to WT 6475. Expression ratios of each gene (6475eriC-Stop mutant vs wild-type) were calculated, and results represent the mean ± SD, n = 3, *p value \ 0.05, **p value \ 0.01 using one-sample t test compared to the theoretical mean of 1.0. b Gene expression of the hdc cluster in both 6475eriC-Stop and WT 6475 were compared in the presence and absence of supplemental Lhistidine. RT-qPCR demonstrated increased expression of all hdc genes in WT L. reuteri 6475 when grown in the presence or absence of supplemental L-histidine. Changes in expression of the same genes in 6475eriC-Stop were insignificant in the presence of added L-histidine. Expression ratios of each gene (histidine-supplemented vs unsupplemented) were calculated. Results represent the mean ± SD, n = 3, ***p value \ 0.005, **p value \ 0.01, *p value \ 0.05 compared to the theoretical mean of 1.0. All RT-qPCR data were normalized to a reference gene rpoB Antonie van Leeuwenhoek (2014) 105:579-592 587 reuteri 6475 EriC sequence revealed that proteins with EriC functional domains are ubiquitously present in bacteria including those that are members of the human intestinal microbiome. As previously discussed in the introduction, we recently revealed histamine as one of the immunomodulatory factors produced by L. reuteri 6475. Production of biogenic amines, including histamine, through microbial decarboxylation have been reported in various types of foods (Naila et al. 2011 ). Histamine poisoning (or scromboid poisoning), which could result in symptoms that resemble severe allergic reactions, occurs after consumption of foods contaminated with highly elevated quantities of histamine, mostly at concentrations higher than 0.5 mg/mL (Hungerford 2010; Gonzaga et al. 2009 ). Despite the potential health risk of histamine-contaminated foods whereby histamine is generated in food prior to consumption, histamine may promote healthy development and physiology of the intestinal epithelium and the gut immune system (O'Mahony et al. 2011) . Selective blockade of histamine receptors type 1 and 2 resulted in impaired innate immune responses in a mouse model (Metz et al. 2011) . Moreover, histamine receptor antagonists have been associated with increased incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight infants (Guillet et al. 2006 ) and Crohn's disease (Juillerat et al. 2012) . These findings suggest an immunomodulatory role of histamine in the human gastrointestinal tract. L. reuteri 6475 was shown to be able to produce histamine via decarboxylation of L-histidine at low concentrations relative to what is considered toxic when orally consumed (Thomas et al. 2012) . Mutants that failed to produce histamine were unable to suppress TNF production by THP-1 cells and yielded diminished protective effects in a TNBS-induced mouse model of acute colitis (Hemarajata et al. 2013; Thomas et al. 2012) . Patients suffering from inflammatory bowel disease could benefit from the bacteria-mediated conversion of histidine in the diet to histamine in the lumen of the gastrointestinal tract.
The production of histamine and expression of the hdc gene cluster in an EriC-deficient mutant were diminished compared to WT 6475. Degradative amino acid decarboxylation is a highly efficient bacterial mechanism for withstanding the extreme acidic environment in the gastrointestinal tract and for generating secondary metabolic energy (Gut et al. 2006) . Genetic elements involved in amino acid decarboxylation are part of the conserved functional core genes of the healthy human intestinal microbiome, suggesting their essential contribution to the function and maintenance of the gut microbial community as a whole (The Human Microbiome Project Consortium 2012a).
Amino acid decarboxylation results in the production of biogenic amines and helps regulate bacterial intracellular pH in the presence of acid stress. A single proton is consumed during the decarboxylation of each amino acid molecule, resulting in alkalinization of the cytoplasm (Romano et al. 2012) . Many gut microbes, including lactic acid bacteria, are able to convert glutamate to c-aminobutyrate (Cotter and Hill 2003) , arginine to agmatine (Iyer et al. 2003) , lysine to cadaverine (Lin et al. 1995) , ornithine to putrescine (Romano et al. 2012; Azcarate-Peril et al. 2004 ) and histidine to histamine (Romano et al. 2012 ). An intestinal bacterium, E. coli, was shown to have at least four different mechanisms for acid resistance and maintenance of transmembrane potential, and three of those mechanisms specifically rely on the decarboxylation of glutamate, arginine, and lysine and involve EriC (Richard and Foster 2004) . L. reuteri 100-23, a murine-derived L. reuteri strain, contains a glutamate decarboxylase system involved in acid resistance during sourdough fermentations (Su et al. 2011) . The human microbiome resident, L. reuteri 6475, also possesses genetic elements required for decarboxylation of glutamate and histidine but the role of these processes in regulation of membrane potential and response to acid stress has not been characterized. Decarboxylation of Lhistidine and the subsequent histamine production by lactobacilli was first identified and characterized in a horse isolate of Lactobacillus saerimneri ATCC 33222 (formerly known as Lactobacillus sp. strain 30a). (Rodwell 1953) . A functional hdc gene cluster, with the histidine decarboxylase pyruvoyl type (hdcA), a putative helper protein (hdcB) and a histidine/histamine antiporter (hdcP), is found in histaminogenic strains of Lactobacillus (Rossi et al. 2011) . Metabolic factors such as pH, the concentration of free L-histidine and the presence of other carbon sources could affect the expression of genes in the hdc gene cluster (Pessione et al. 2005; Landete et al. 2006 Landete et al. , 2008 . Genetic elements such as rsiR may regulate the expression of these hdc genes as well (Hemarajata et al. 2013) .
Amino acid decarboxylation is an electrogenic process where an accumulation of intracellular negative transmembrane potential occurs as protons are virtually driven out of the bacterial cell. The increasing negative transmembrane potential may antagonize amino acid decarboxylation and ultimately lead to the decreased production of biogenic amines (Iyer et al. 2002) . EriC in E. coli functions as an electrical shunt, facilitating proton entry with the simultaneous export of chloride, relieving the accumulated negative intracellular charge and allowing amino acid decarboxylation to continue (Supplement Fig. S4) . We propose that EriC may perform the same function in L. reuteri. EriC-deficient L. reuteri may be unable to alleviate increasing intracellular negative charges by failing to replenish the intracellular protons needed for histidine decarboxylation. In turn, this may result in the inhibition of histidine decarboxylation, diminished histamine production and loss of TNF suppression in human immune cells. Inactivation of eriC also affected hdc cluster gene expression. Expression of genes involved in glutamate decarboxylation and the acid resistance mechanism in L. lactis (Sanders et al. 1998 ) and E. coli (De Biase and Pennacchietti 2012) were influenced by the amounts of chloride in growth media and intracellular pH. In the EriC-deficient mutant, regulation of intracellular anions and pH may also be altered and result in an indirect effect upon hdc gene cluster expression. The role of L. reuteri EriC in transmembrane potential maintenance could be further characterized by comparing intracellular pH (using 2,7-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein (Molenaar et al. 1991) ) and membrane potential (with 3,3 0 -dipropylthiodicarbocyanine (Sip et al. 1990 )) between those of WT 6475 and the EriC-deficient mutant in the presence or absence of the recently discovered CIC-specific inhibitor, 4,4 0 -octanamidostilbene-2,2 0 -disulfonate (OADS) (Howery et al. 2012) .
The successful implementation of our novel Himar1 Tn-mutagenesis system in immunomodulatory gene discovery is a significant advance in the field of L. reuteri functional genomics. This system enables the identification of genetic elements from large Tn-mutant libraries that can be screened in high-throughput methods for any loss-of-function phenotype. Further screening of random mutants generated from this system could help identify additional genes that may be involved in L. reuteri-mediated immunomodulation. We identified EriC as one of the major players in a putative regulatory mechanism for histidine decarboxylation in L. reuteri. The importance of EriC in histidine metabolism highlights the significance of EriC as a member in the immunomodulatory gene network of L. reuteri 6475, and the potential importance of ion transporters in amino acid metabolism and immunomodulation by the gut microbiome. Future manipulation of immunomodulatory gene networks important for L-histidine decarboxylation and histamine biosynthesis could facilitate the development of next generation probiotics with enhanced immunoregulatory functions. More broadly, dietary modifications can be coupled with specific probiotic strains to maximize immunomodulatory functions of gut-derived microbes in future microbiome-based therapeutics for disorders of intestinal inflammation including inflammatory bowel disease.
